Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

668 Articles

Jon C. Ogg | Nov 8, 2018 at 12:45 PM EST

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to…

Chris Lange | Nov 6, 2018 at 10:20 AM EST

Eli Lilly Dips Despite Solid Q3 Results

Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.

Chris Lange | Nov 5, 2018 at 11:25 AM EST

What to Watch For When Eli Lilly Reports Tuesday Morning

Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.

Jon C. Ogg | Oct 31, 2018 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Baker Hughes, Chesapeake Energy, Cognizant, Cummins, Eli Lilly, GE, Qualcomm, Weatherford and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Aetna, Baker Hughes, Chesapeake Energy, Cognizant Technology Solutions, Cummins,…

Chris Lange | Oct 29, 2018 at 9:45 AM EDT

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development…

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Oct 5, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

The top analyst upgrades, downgrades and initiations seen on Friday included Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 22, 2018 at 7:20 AM EDT

The Top IPOs From This Week

With the markets at all-time highs, it is prime season for initial public offerings and companies can get more bang…

Chris Lange | Sep 20, 2018 at 1:45 PM EDT

Elanco Explodes Into the Market in IPO

Eli Lilly spin-off Elanco Animal Health made a strong entrance to the market on Thursday.

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 29, 2018 at 12:15 PM EDT

Elanco Closes in on IPO

Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

1 … 20 21 22 23 24 … 45

Eli Lilly : LLY

All Eli Lilly Articles

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

Eli Lilly Dips Despite Solid Q3 Results

What to Watch For When Eli Lilly Reports Tuesday Morning

Top Analyst Upgrades and Downgrades: Aetna, Baker Hughes, Chesapeake Energy, Cognizant, Cummins, Eli Lilly, GE, Qualcomm, Weatherford and More

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Major Pharma Short Sellers Hike Their Bets

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

Short Sellers Grow More Selective on Major Pharma Stocks

The Top IPOs From This Week

Elanco Explodes Into the Market in IPO

Short Sellers Back Off Major Pharma Stocks

Elanco Closes in on IPO

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story

Tesla Is $370: Should You Buy?

SK Hynix Rockets 14% Ahead of July 29 Earnings as Chip Stocks Rebound

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story

Tesla Is $370: Should You Buy?

Eli Lilly : LLY

All Eli Lilly Articles

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

Eli Lilly Dips Despite Solid Q3 Results

What to Watch For When Eli Lilly Reports Tuesday Morning

Top Analyst Upgrades and Downgrades: Aetna, Baker Hughes, Chesapeake Energy, Cognizant, Cummins, Eli Lilly, GE, Qualcomm, Weatherford and More

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Major Pharma Short Sellers Hike Their Bets

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

Short Sellers Grow More Selective on Major Pharma Stocks

The Top IPOs From This Week

Elanco Explodes Into the Market in IPO

Short Sellers Back Off Major Pharma Stocks

Elanco Closes in on IPO

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story

Tesla Is $370: Should You Buy?

SK Hynix Rockets 14% Ahead of July 29 Earnings as Chip Stocks Rebound

Featured Reads

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.